Status:
UNKNOWN
Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease
Lead Sponsor:
Minneapolis Heart Institute Foundation
Conditions:
Disparities in Treatment of Aortic Valve Stenosis
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
Common barriers to receiving appropriate guideline-driven care for patients with severe aortic stenosis include referral biases by primary care providers (lack of provider education), patient comorbid...
Eligibility Criteria
Inclusion
- Disparity/Diversity background (either race/ethnicity, low SES (adults with incomes at or below the federal poverty level (family income to poverty ratio, ≤1), language (non-English speaker) or education (≤9 years of education))
- Patient scheduled for transcatheter aortic valve replacement using the Edwards Sapien valve, OR recently implanted with Edwards Sapien valve (up to 1 year post-TAVR)
- Echocardiographic diagnosis of severe, symptomatic AS and intermediate to high surgical risk per Society of Thoracic Surgeons (STS) mortality risk-score
Exclusion
- Age \< 18
- Patients who do not allow their records to be used for research
Key Trial Info
Start Date :
June 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04525937
Start Date
June 4 2018
End Date
August 1 2022
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States, 55407